These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 22571256
1. In-vivo pharmacokinetics, tissue distribution and anti-tumour effect of hydroxycamptothecin delivered in oil-in-water submicron emulsions. Zhao YX, Liu DX, Liang WQ, Ye ZW. J Pharm Pharmacol; 2012 Jun; 64(6):783-91. PubMed ID: 22571256 [Abstract] [Full Text] [Related]
2. Pharmacokinetics, tissue distribution and anti-tumour efficacy of paclitaxel delivered by polyvinylpyrrolidone solid dispersion. Liu X, Sun J, Chen X, Wang S, Scott H, Zhang X, Zhang Q. J Pharm Pharmacol; 2012 Jun; 64(6):775-82. PubMed ID: 22571255 [Abstract] [Full Text] [Related]
3. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles. Hong M, Zhu S, Jiang Y, Tang G, Sun C, Fang C, Shi B, Pei Y. J Control Release; 2010 Jan 04; 141(1):22-9. PubMed ID: 19735683 [Abstract] [Full Text] [Related]
4. Cationic submicron emulsions overcome multidrug resistance in SGC7901/VCR cells. Zhao YX, Liang WQ, Wang Y, Liu DX. Pharmazie; 2011 Feb 04; 66(2):130-5. PubMed ID: 21434576 [Abstract] [Full Text] [Related]
5. Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I. Zhang R, Li Y, Cai Q, Liu T, Sun H, Chambless B. Cancer Chemother Pharmacol; 1998 Feb 04; 41(4):257-67. PubMed ID: 9488594 [Abstract] [Full Text] [Related]
8. A pH-responsive prodrug delivery system of 10-HCPT for controlled release and tumor targeting. Liu Y, Li D, Guo X, Xu H, Li Z, Zhang Y, Song C, Fan R, Tang X, Zhang Z. Int J Nanomedicine; 2017 Feb 04; 12():2227-2242. PubMed ID: 28356739 [Abstract] [Full Text] [Related]
11. Preparation and in vitro and in vivo evaluations of 10-hydroxycamptothecin liposomes modified with stearyl glycyrrhetinate. Zhou T, Tang X, Zhang W, Feng J, Wu W. Drug Deliv; 2019 Dec 04; 26(1):673-679. PubMed ID: 31266376 [Abstract] [Full Text] [Related]
15. Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application. Wei W, Shi SJ, Liu J, Sun X, Ren K, Zhao D, Zhang XN, Zhang ZR, Gong T. J Drug Target; 2010 Aug 04; 18(7):557-66. PubMed ID: 20131981 [Abstract] [Full Text] [Related]
16. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin. Hong M, Zhu S, Jiang Y, Tang G, Pei Y. J Control Release; 2009 Jan 19; 133(2):96-102. PubMed ID: 18840485 [Abstract] [Full Text] [Related]
18. Preparation, characterization, biodistribution and antitumor efficacy of hydroxycamptothecin nanosuspensions. Han M, Liu X, Guo Y, Wang Y, Wang X. Int J Pharm; 2013 Oct 15; 455(1-2):85-92. PubMed ID: 23928147 [Abstract] [Full Text] [Related]
19. [Preparation of PEG-modified nanostructured lipid carriers loaded with hydroxycamptothecin and tissue distribution in mice]. Zhang XX, Gan Y, Yang XG, Zhu CL, Gan L, Nie SF, Pan WS. Yao Xue Xue Bao; 2008 Jan 15; 43(1):91-6. PubMed ID: 18357740 [Abstract] [Full Text] [Related]
20. Hydroxyethyl starch conjugates for improving the stability, pharmacokinetic behavior and antitumor activity of 10-hydroxy camptothecin. Li G, Li Y, Tang Y, Zhang Y, Zhang Y, Yin T, Xu H, Cai C, Tang X. Int J Pharm; 2014 Aug 25; 471(1-2):234-44. PubMed ID: 24861941 [Abstract] [Full Text] [Related] Page: [Next] [New Search]